● Recruiting

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Condition: Peptic Ulcer · Sponsor: Il-Yang Pharm. Co., Ltd.

PhasePhase 3

Planned participants416

Who can joinAll sexes, 19 Years to no upper limit

Healthy volunteersNo

About this study

To demonstrate the non-inferiority of Ilaprazole 10 mg to the active control in prevention of NSAIDs-associated peptic ulcer, as assessed by the proportion of subjects with peptic ulcer by Week 24

This description comes directly from the study's public registry record.

Talk to the study team

JungHwa Hong, Master · +82.2.570.3777 · jhhong@ilyang.co.kr

JeongSu Wi, bachelor · +82.2.570.3778 · jswi@ilyang.co.kr

Always discuss trial participation with your own doctor first.

Locations (2)

Chung Ang University Hospital	Seoul, South Korea	Recruiting
Chung-Ang University Hospital	Seoul, South Korea	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06284876